{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:30:57Z","timestamp":1761975057207,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jaip.2020.01.028","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T02:42:03Z","timestamp":1580179323000},"page":"2075-2076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Toxicological screening reveals toxic\u00a0epidermal necrolysis likely carbamazepine-induced rather than idiopathic"],"prefix":"10.1016","volume":"8","author":[{"given":"Clementine","family":"Toussaint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Sanchez-Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Titier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadege","family":"Castaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Molimard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.01.028_bib1","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3390\/ijms17122135","article-title":"Review of toxic epidermal necrolysis","volume":"17","author":"Harris","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2020.01.028_bib2","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.01.028_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13023-018-0793-7","article-title":"Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)","volume":"13","author":"Ingen-Housz-Oro","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2020.01.028_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/026988119701100119","article-title":"Is carbamazepine a potential drug of abuse?","volume":"11","author":"Sullivan","year":"1997","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaip.2020.01.028_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1155\/2018\/3201203","article-title":"A\u00a0clinical study of toxication caused by carbamazepine abuse in adolescents","volume":"2018","author":"Xu","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jaip.2020.01.028_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-61779-934-1_3","article-title":"LC-MS\/MS techniques for high-volume screening of drugs of abuse and target drug quantitation in urine\/blood matrices","volume":"902","author":"Eichhorst","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaip.2020.01.028_bib7","first-page":"5","article-title":"LC-MS\/MS in the clinical laboratory\u2014where to from here?","volume":"32","author":"Grebe","year":"2011","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jaip.2020.01.028_bib8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jms.1112","article-title":"Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control","volume":"41","author":"Maurer","year":"2006","journal-title":"J\u00a0Mass Spectrom"},{"key":"10.1016\/j.jaip.2020.01.028_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2020.01.028_bib10","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.3390\/pharmaceutics11100536","article-title":"The mechanistic differences in HLA-associated carbamazepine hypersensitivity","volume":"11","author":"Simper","year":"2019","journal-title":"Pharmaceutics"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820300684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820300684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:23:06Z","timestamp":1761974586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820300684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2213219820300684"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.01.028","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicological screening reveals toxic\u00a0epidermal necrolysis likely carbamazepine-induced rather than idiopathic","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}